News Articles for Jason Loveridge

Invex Therapeutics has received a $5 million investment from Andrew Forrest's Tattarang as part of a share placement, with the proceeds to go towards the company's research into neurological diseases.

Invex Therapeutics has become just the third WA-based company to list on the ASX this year, with Minderoo Group its largest shareholder.

Jason Loveridge has retired as non-executive director of Actinogen Medical.

Stephen Jones has been appointed chief financial officer of Kin Mining.

Martin Rogers has resigned as executive chair and director of Actinogen Medical. Mr Rogers has been chairman since Actinogen Medical's inception in late 2014.